Tranexamic acid in ovarian cancer surgery
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how the drug tranexamic acid (TXA) works in the body during and after surgery for advanced ovarian cancer. It aims to find the best dose to help control bleeding without increasing the risk of blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 20 and 64 years old.
- You must have advanced ovarian cancer (stage III or IV).
- You must be scheduled for surgery to remove the tumors, and the surgery should last longer than 2 hours.
- You cannot have serious kidney or liver problems.
- You cannot have a history of bleeding disorders, blood clots, or have taken blood thinners in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether giving tranexamic acid through a vein during gender-affirming mastectomy can safely reduce bleeding. It may help lower blood loss and related complications during surgery.
This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.
This trial tests whether a medicine called TXA (tranexamic acid) can help reduce bleeding during breast reconstruction using your own abdominal tissue. It's for women having this surgery at UVA Medical Center.
This Phase 3 trial tests whether giving tranexamic acid (a medicine that helps reduce bleeding) around the time of surgery can improve outcomes for people with invasive skin melanoma. It may help reduce surgical bleeding while keeping patients safe.
This trial tests whether tranexamic acid (a medicine that helps reduce bleeding) lowers bleeding during colon procedures where abnormal growths are removed with a flexible camera. You might benefit if you’re having one of these colonoscopic resection procedures and don’t have certain key risk factors.
This trial tests if giving tranexamic acid (TXA) during urethroplasty (surgery to fix a narrowed urethra) helps reduce bleeding. It may help patients who are having this surgery for a urethral stricture.
Hear when a new Carcinoma, Ovarian Epithelial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.